|
|
|
Research Papers
Howard Hughes Medical Institute, University of California, San Diego, La Jolla 90293-0648, USA.
Abstract
Transcriptional activation of the prolactin and growth hormone genes, occurring in a cell-specific fashion, requires short-range synergistic interactions between the pituitary-specific POU domain factor Pit-1 and other transcription factors, particularly nuclear receptors. Unexpectedly, we find that these events involve the gene-specific use of alternative Pit-1 synergy domains. Synergistic activation of the prolactin gene by Pit-1 and the estrogen receptor requires a Pit-1 amino-terminal 25-amino-acid domain that is not required for analogous synergistic activation of the growth hormone promoter. The action of this Pit-1 synergy domain is dependent on the presence of two of three tyrosine residues spaced by 6 amino acids and can be replaced by a comparable tyrosine-dependent trans-activation domain of an unrelated transcription factor (hLEF). The gene-specific utilization of this tyrosine-dependent synergy domain is conferred by specific Pit-1 DNA-binding sites that determine whether Pit-1 binds as a monomer or a dimer. Thus, the critical DNA site in the prolactin enhancer, where this domain is required, binds Pit-1 as a monomer, whereas the Pit-1 sites in the growth hormone gene, which do not utilize this synergy domain, bind Pit-1 as a dimer. The finding that the sequence of specific DNA sites dictates alternative Pit-1 synergy domain utilization based on monomeric or dimeric binding suggests an additional regulatory strategy for differential target gene activation in distinct cell types.
This article has been cited by other articles:
![]() |
D. L. Duval, M. D. Jonsen, S. E. Diamond, P. Murapa, A. Jean, and A. Gutierrez-Hartmann Differential Utilization of Transcription Activation Subdomains by Distinct Coactivators Regulates Pit-1 Basal and Ras Responsiveness Mol. Endocrinol., January 1, 2007; 21(1): 172 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pellegrini, C. Roche, M.-H. Quentien, M. Ferrand, G. Gunz, S. Thirion, C. Bagnis, A. Enjalbert, and J.-L. Franc Involvement of the Pituitary-Specific Transcription Factor Pit-1 in Somatolactotrope Cell Growth and Death: An Approach Using Dominant-Negative Pit-1 Mutants Mol. Endocrinol., December 1, 2006; 20(12): 3212 - 3227. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. D. Sharp, M. G. Mancini, C. A. Hinojos, F. Dai, V. Berno, A. T. Szafran, K. P. Smith, T. T. Lele, D. E. Ingber, and M. A. Mancini Estrogen-receptor-{alpha} exchange and chromatin dynamics are ligand- and domain-dependent J. Cell Sci., October 1, 2006; 119(19): 4101 - 4116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Guise, A. Lacerte, S. Rafiei, R. Reynaud, M. Roy, T. Brue, and J.-J. Lebrun Activin Inhibits the Human Pit-1 Gene Promoter through the p38 Kinase Pathway in a Smad-Independent Manner Endocrinology, September 1, 2006; 147(9): 4351 - 4362. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Cohen, T. Brue, K. Naik, C. A. Houlihan, F. E. Wondisford, and S. Radovick The Role of CBP/p300 Interactions and Pit-1 Dimerization in the Pathophysiological Mechanism of Combined Pituitary Hormone Deficiency J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 239 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. G. Turton, R. Reynaud, A. Mehta, J. Torpiano, A. Saveanu, K. S. Woods, A. Tiulpakov, V. Zdravkovic, J. Hamilton, S. Attard-Montalto, et al. Novel Mutations within the POU1F1 Gene Associated with Variable Combined Pituitary Hormone Deficiency J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4762 - 4770. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Ferry, D M Locasto, L B Meszaros, J C Bailey, M D Jonsen, K Brodsky, C J Hoon, A Gutierrez-Hartmann, and S E Diamond Pit-1{beta} reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner J. Endocrinol., April 1, 2005; 185(1): 173 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Duval, A. Jean, and A. Gutierrez-Hartmann Ras Signaling and Transcriptional Synergy at a Flexible Ets-1/Pit-1 Composite DNA Element Is Defined by the Assembly of Selective Activation Domains J. Biol. Chem., October 10, 2003; 278(41): 39684 - 39696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Zelhof, E. Koundakjian, A. L. Scully, R. W. Hardy, and L. Pounds Mutation of the photoreceptor specific homeodomain gene Pph13 results in defects in phototransduction and rhabdomere morphogenesis Development, September 15, 2003; 130(18): 4383 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hashimoto, M. Cisternino, and L. E. Cohen A Novel Nonsense Mutation in the Pit-1 Gene: Evidence for a Gene Dosage Effect J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1241 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cohen and S. Radovick Molecular Basis of Combined Pituitary Hormone Deficiencies Endocr. Rev., August 1, 2002; 23(4): 431 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Manfroid, J. A. Martial, and M. Muller Inhibition of Protein Phosphatase PP1 in GH3B6, but Not in GH3 Cells, Activates the MEK/ERK/c-fos Pathway and the Human Prolactin Promoter, Involving the Coactivator CBP/p300 Mol. Endocrinol., April 1, 2001; 15(4): 625 - 637. [Abstract] [Full Text] |
||||
![]() |
B. Andersen and M. G. Rosenfeld POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease Endocr. Rev., February 1, 2001; 22(1): 2 - 35. [Abstract] [Full Text] |
||||
![]() |
A. P. Bradford, K. S. Brodsky, S. E. Diamond, L. C. Kuhn, Y. Liu, and A. Gutierrez-Hartmann The Pit-1 Homeodomain and beta -Domain Interact with Ets-1 and Modulate Synergistic Activation of the Rat Prolactin Promoter J. Biol. Chem., February 4, 2000; 275(5): 3100 - 3106. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Shewchuk, S. L. Asa, N. E. Cooke, and S. A. Liebhaber Pit-1 Binding Sites at the Somatotrope-specific DNase I Hypersensitive Sites I, II of the Human Growth Hormone Locus Control Region Are Essential for in Vivo hGH-N Gene Activation J. Biol. Chem., December 10, 1999; 274(50): 35725 - 35733. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Prefontaine, R. Walther, W. Giffin, M. E. Lemieux, L. Pope, and R. J. G. Hache Selective Binding of Steroid Hormone Receptors to Octamer Transcription Factors Determines Transcriptional Synergism at the Mouse Mammary Tumor Virus Promoter J. Biol. Chem., September 17, 1999; 274(38): 26713 - 26719. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kakizawa, T. Miyamoto, K. Ichikawa, A. Kaneko, S. Suzuki, M. Hara, T. Nagasawa, T. Takeda, J.-i. Mori, M. Kumagai, et al. Functional Interaction between Oct-1 and Retinoid X Receptor J. Biol. Chem., July 2, 1999; 274(27): 19103 - 19108. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schaufele Regulation of Estrogen Receptor Activation of the Prolactin Enhancer/Promoter by Antagonistic Activation Function-2-Interacting Proteins Mol. Endocrinol., June 1, 1999; 13(6): 935 - 945. [Abstract] [Full Text] |
||||
![]() |
U. R. Chandran, B. S. Warren, C. T. Baumann, G. L. Hager, and D. B. DeFranco The Glucocorticoid Receptor Is Tethered to DNA-bound Oct-1 at the Mouse Gonadotropin-releasing Hormone Distal Negative Glucocorticoid Response Element J. Biol. Chem., January 22, 1999; 274(4): 2372 - 2378. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Day, J. Liu, V. Sundmark, M. Kawecki, D. Berry, and H. P. Elsholtz Selective Inhibition of Prolactin Gene Transcription by the ETS-2 Repressor Factor J. Biol. Chem., November 27, 1998; 273(48): 31909 - 31915. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Palomino, D. Barettino, and A. Aranda Role of GHF-1 in the Regulation of the Rat Growth Hormone Gene Promoter by Thyroid Hormone and Retinoic Acid Receptors J. Biol. Chem., October 16, 1998; 273(42): 27541 - 27547. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Budhram-Mahadeo, M. Parker, and D. S. Latchman POU Transcription Factors Brn-3a and Brn-3b Interact with the Estrogen Receptor and Differentially Regulate Transcriptional Activity via an Estrogen Response Element Mol. Cell. Biol., February 1, 1998; 18(2): 1029 - 1041. [Abstract] [Full Text] |
||||
![]() |
D. F. Gordon, S. R. Lewis, B. R. Haugen, R. A. James, M. T. McDermott, W. M. Wood, and E. C. Ridgway Pit-1 and GATA-2 Interact and Functionally Cooperate to Activate the Thyrotropin beta -Subunit Promoter J. Biol. Chem., September 26, 1997; 272(39): 24339 - 24347. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Chuang, B. L. West, J. D. Baxter, and F. Schaufele Activities in Pit-1 Determine Whether Receptor Interacting Protein 140 Activates or Inhibits Pit-1/Nuclear Receptor Transcriptional Synergy Mol. Endocrinol., August 1, 1997; 11(9): 1332 - 1341. [Abstract] [Full Text] |
||||
![]() |
K. M. Scully, A. S. Gleiberman, J. Lindzey, D. B. Lubahn, K. S. Korach, and M. G. Rosenfeld Role of Estrogen Receptor-{{alpha}} in the Anterior Pituitary Gland Mol. Endocrinol., June 1, 1997; 11(6): 674 - 681. [Abstract] [Full Text] |
||||
![]() |
A K Ryan and M G Rosenfeld POU domain family values: flexibility, partnerships, and developmental codes. Genes & Dev., May 15, 1997; 11(10): 1207 - 1225. [PDF] |
||||
![]() |
L Bruhn, A Munnerlyn, and R Grosschedl ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes & Dev., March 1, 1997; 11(5): 640 - 653. [Abstract] [PDF] |
||||
![]() |
E M Jacobson, P Li, A Leon-del-Rio, M G Rosenfeld, and A K Aggarwal Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes & Dev., January 15, 1997; 11(2): 198 - 212. [Abstract] [PDF] |
||||
![]() |
M. Delhase, J.-L. Castrillo, M. de la Hoya, F. Rajas, and E. L. Hooghe-Peters AP-1 and Oct-1 Transcription Factors Down-regulate the Expression of the Human PIT1/GHF1 Gene J. Biol. Chem., December 13, 1996; 271(50): 32349 - 32358. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Davis-Smyth, R. C. Duncan, T. Zheng, G. Michelotti, and D. Levens The Far Upstream Element-binding Proteins Comprise an Ancient Family of Single-strand DNA-binding Transactivators J. Biol. Chem., December 6, 1996; 271(49): 31679 - 31687. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Wood, J. M. Dowding, T. M. Bright, M. T. McDermott, B. R. Haugen, D. F. Gordon, and E. C. Ridgway Thyroid Hormone Receptor beta 2 Promoter Activity in Pituitary Cells Is Regulated by Pit-1 J. Biol. Chem., September 27, 1996; 271(39): 24213 - 24220. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. R. Chandran, B. Attardi, R. Friedman, Z.-w. Zheng, J. L. Roberts, and D. B. DeFranco Glucocorticoid Repression of the Mouse Gonadotropin-releasing Hormone Gene Is Mediated by Promoter Elements That Are Recognized by Heteromeric Complexes Containing Glucocorticoid Receptor J. Biol. Chem., August 23, 1996; 271(34): 20412 - 20420. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chang, W. Zhou, L. E. Theill, J. D. Baxter, and F. Schaufele An Activation Function in Pit-1 Required Selectively for Synergistic Transcription J. Biol. Chem., July 26, 1996; 271(30): 17733 - 17738. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Anderson, S. Certel, K Certel, T Lee, D. Montell, and W. Johnson Function of the Drosophila POU domain transcription factor drifter as an upstream regulator of breathless receptor tyrosine kinase expression in developing trachea Development, January 12, 1996; 122(12): 4169 - 4178. [Abstract] [PDF] |
||||